RVMI: Identifying Incorrect Statements

This section analyzes the provided statements about right ventricular myocardial infarction (RVMI) to identify the one that is incorrect.

Association with Inferior Wall MI

Right Ventricular Myocardial Infarction (RVMI) frequently occurs alongside inferior wall myocardial infarction (IWMI). This co-occurrence is common because the right ventricle and the inferior wall of the left ventricle often share blood supply, typically from the posterior descending artery. Therefore, statement 1 is considered correct.

ECG Findings in RVMI

Diagnosis of RVMI often involves specific electrocardiogram (ECG) findings. An elevation in the ST segment, particularly in the right precordial leads like lead V4R, is a characteristic sign pointing towards RVMI. Consequently, statement 2 is accurate.

Prognosis of RVMI vs. LVMI

The prognosis of RVMI can be complex. While RVMI can cause serious issues such as right heart failure and hemodynamic compromise, it is not universally true that its prognosis is worse than all cases of left ventricular myocardial infarction (LVMI). Isolated RVMI might even carry a better prognosis than extensive LVMI. However, RVMI associated with IWMI can present a poorer outlook. Statement 3 is a generalization that may not always apply, but it is less definitively incorrect than other options in certain clinical scenarios.

Treatment Contraindications in RVMI

Managing RVMI demands careful attention to the patient's hemodynamics. The right ventricle's function is highly dependent on adequate preload (the volume of blood returning to the heart). Medications like intravenous diltiazem, a type of calcium channel blocker, can negatively impact this.

Diltiazem can cause:

• Vasodilation: Widening of blood vessels, which reduces blood pressure.
• Negative Inotropy: Weakening of the heart muscle's contraction force.

In a patient with RVMI, whose cardiac output is sensitive to preload, these effects can lead to a significant drop in blood pressure (hypotension) and a further decrease in overall cardiac output. Therefore, administering intravenous diltiazem is generally considered contraindicated in RVMI.

Statement 4, suggesting the treatment includes intravenous diltiazem, is incorrect.

Conclusion

The question asks to identify the statement that is an exception, meaning the incorrect statement regarding RVMI. Based on the analysis, the use of intravenous diltiazem is contraindicated in RVMI due to potential adverse hemodynamic effects. Thus, the statement claiming it is part of the treatment is false.

The incorrect statement is: The treatment includes intravenous diltiazem.